

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.46743789 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.31096609 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23397161 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01831610 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.96631975 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.96631975 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 4.94244107 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.93350740 |
| 9 | leukocyte aggregation (GO:0070486) | 4.65049600 |
| 10 | detection of bacterium (GO:0016045) | 4.42664624 |
| 11 | cellular response to type I interferon (GO:0071357) | 4.39656716 |
| 12 | type I interferon signaling pathway (GO:0060337) | 4.39656716 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.37778634 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.37778634 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.37778634 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.37778634 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.37778634 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.37778634 |
| 19 | response to type I interferon (GO:0034340) | 4.34962163 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.30728922 |
| 21 | detection of other organism (GO:0098543) | 4.28919433 |
| 22 | T cell migration (GO:0072678) | 4.08634812 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.02413309 |
| 24 | B cell mediated immunity (GO:0019724) | 3.99644699 |
| 25 | T-helper 1 type immune response (GO:0042088) | 3.90845707 |
| 26 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.75032762 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.74736088 |
| 28 | response to peptidoglycan (GO:0032494) | 3.74324431 |
| 29 | negative thymic T cell selection (GO:0045060) | 3.74213083 |
| 30 | NIK/NF-kappaB signaling (GO:0038061) | 3.74208929 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.72079996 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.64393512 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.62096120 |
| 34 | negative T cell selection (GO:0043383) | 3.59089837 |
| 35 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57681968 |
| 36 | defense response to protozoan (GO:0042832) | 3.56033785 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.54386754 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.54215709 |
| 39 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.52805010 |
| 40 | response to interleukin-15 (GO:0070672) | 3.51506256 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.51466976 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48539258 |
| 43 | response to protozoan (GO:0001562) | 3.48001189 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.39502547 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.39474995 |
| 46 | myeloid dendritic cell differentiation (GO:0043011) | 3.37210846 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 3.36113105 |
| 48 | myeloid dendritic cell activation (GO:0001773) | 3.35176241 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34851689 |
| 50 | response to host immune response (GO:0052572) | 3.32888433 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32888433 |
| 52 | regulation of antigen processing and presentation (GO:0002577) | 3.27020629 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26881814 |
| 54 | detection of external biotic stimulus (GO:0098581) | 3.26555725 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24308744 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.21633394 |
| 57 | regulation of B cell differentiation (GO:0045577) | 3.17710030 |
| 58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15940693 |
| 59 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.15273739 |
| 60 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13691021 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.10904158 |
| 62 | positive regulation of interferon-alpha production (GO:0032727) | 3.09914665 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09817278 |
| 64 | regulation of interferon-alpha production (GO:0032647) | 3.09688297 |
| 65 | negative regulation of innate immune response (GO:0045824) | 3.09682574 |
| 66 | microglial cell activation (GO:0001774) | 3.06048678 |
| 67 | response to host defenses (GO:0052200) | 3.03715068 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03715068 |
| 69 | response to host (GO:0075136) | 3.03715068 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02871187 |
| 71 | thymic T cell selection (GO:0045061) | 2.98426025 |
| 72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98378445 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.96234752 |
| 74 | respiratory burst (GO:0045730) | 2.95678152 |
| 75 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.95083856 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.91070189 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.91070189 |
| 78 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.90753889 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90546889 |
| 80 | response to interferon-beta (GO:0035456) | 2.90389024 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89286833 |
| 82 | germinal center formation (GO:0002467) | 2.88526547 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88001329 |
| 84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.87642279 |
| 85 | detection of biotic stimulus (GO:0009595) | 2.87229942 |
| 86 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.87106167 |
| 87 | positive regulation of B cell mediated immunity (GO:0002714) | 2.87106167 |
| 88 | positive T cell selection (GO:0043368) | 2.86635827 |
| 89 | cellular response to interferon-gamma (GO:0071346) | 2.85592299 |
| 90 | cellular extravasation (GO:0045123) | 2.84330476 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83032829 |
| 92 | negative regulation of B cell apoptotic process (GO:0002903) | 2.82890794 |
| 93 | tolerance induction (GO:0002507) | 2.82597667 |
| 94 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.81745598 |
| 95 | regulation of B cell apoptotic process (GO:0002902) | 2.79745866 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 2.79165086 |
| 97 | positive regulation of T cell mediated immunity (GO:0002711) | 2.79077770 |
| 98 | positive regulation of isotype switching (GO:0045830) | 2.78692568 |
| 99 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.78308333 |
| 100 | positive regulation of interleukin-17 production (GO:0032740) | 2.77728787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.85380398 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12972125 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.36141324 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19855598 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.12254852 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07669025 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.98381233 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95123907 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93062615 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.69549291 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.60734548 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.52707384 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.44734719 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41022671 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38563528 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27751854 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.24642202 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24276309 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23660465 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.21533226 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19988169 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18262436 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.17331946 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16269831 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15130721 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11428896 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99510623 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98956966 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94264096 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.93415915 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90849125 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88085629 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.87264726 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85172286 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81997176 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80136238 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75007859 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74198689 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71168839 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69681336 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68139398 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67849843 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64198604 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63747122 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63023573 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54768283 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53972681 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52200080 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51143261 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50302431 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49295550 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46306533 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45789710 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45719036 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45435905 |
| 56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39292707 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37585643 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35061040 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34447866 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32549946 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31934119 |
| 62 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30735925 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30006213 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28381050 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24494851 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23387179 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22943591 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22777718 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22121944 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22108991 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.21586999 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18853780 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18308070 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17053217 |
| 75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15771853 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.13374134 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.08755555 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08513566 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08120459 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07487745 |
| 81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07436191 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06753020 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06700758 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06117360 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03580379 |
| 86 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02476167 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01552145 |
| 88 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00349256 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 0.99637472 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99541568 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97991502 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97882974 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97026993 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95837470 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95640513 |
| 96 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94828492 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94766703 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94194512 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92898885 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92485612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.97526643 |
| 2 | MP0003724_increased_susceptibility_to | 3.84352074 |
| 3 | MP0003436_decreased_susceptibility_to | 3.82879683 |
| 4 | MP0005671_abnormal_response_to | 3.73315625 |
| 5 | MP0000685_abnormal_immune_system | 3.72423449 |
| 6 | MP0003303_peritoneal_inflammation | 3.51205778 |
| 7 | MP0001800_abnormal_humoral_immune | 3.20479536 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.19395572 |
| 9 | MP0005387_immune_system_phenotype | 3.19111511 |
| 10 | MP0001790_abnormal_immune_system | 3.19111511 |
| 11 | MP0009785_altered_susceptibility_to | 2.93801085 |
| 12 | MP0005025_abnormal_response_to | 2.86562480 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.76757201 |
| 14 | MP0002723_abnormal_immune_serum | 2.76095888 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.69197410 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.67136289 |
| 17 | MP0002419_abnormal_innate_immunity | 2.63422028 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.56712801 |
| 19 | MP0001819_abnormal_immune_cell | 2.53586906 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.19234264 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.17005336 |
| 22 | MP0006082_CNS_inflammation | 2.13091176 |
| 23 | MP0002398_abnormal_bone_marrow | 2.11032232 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.07962868 |
| 25 | MP0000716_abnormal_immune_system | 2.02893616 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.02565665 |
| 27 | MP0002405_respiratory_system_inflammati | 1.97246220 |
| 28 | MP0008260_abnormal_autophagy | 1.95132487 |
| 29 | MP0009278_abnormal_bone_marrow | 1.93396476 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.92944259 |
| 31 | MP0004947_skin_inflammation | 1.86759877 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.82863382 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.74793848 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.73143883 |
| 35 | MP0001853_heart_inflammation | 1.72124425 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.68291712 |
| 37 | MP0002429_abnormal_blood_cell | 1.66502083 |
| 38 | MP0002722_abnormal_immune_system | 1.65977466 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.61740691 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.61740691 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.56423166 |
| 42 | MP0002933_joint_inflammation | 1.54592262 |
| 43 | MP0008469_abnormal_protein_level | 1.54488256 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.51437127 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.51396107 |
| 46 | MP0004510_myositis | 1.45378767 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.45249639 |
| 48 | MP0005451_abnormal_body_composition | 1.42275652 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.40737732 |
| 50 | MP0009840_abnormal_foam_cell | 1.40234837 |
| 51 | MP0009764_decreased_sensitivity_to | 1.38809701 |
| 52 | MP0005310_abnormal_salivary_gland | 1.38682357 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.38615098 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.33122460 |
| 55 | MP0001873_stomach_inflammation | 1.31767264 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.29022122 |
| 57 | MP0003866_abnormal_defecation | 1.27971599 |
| 58 | MP0000858_altered_metastatic_potential | 1.23211387 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.19664606 |
| 60 | MP0002132_abnormal_respiratory_system | 1.18963525 |
| 61 | MP0001851_eye_inflammation | 1.15424411 |
| 62 | MP0003075_altered_response_to | 1.12704880 |
| 63 | MP0000604_amyloidosis | 1.05804737 |
| 64 | MP0009763_increased_sensitivity_to | 1.03863944 |
| 65 | MP0002006_tumorigenesis | 1.01238694 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.00098674 |
| 67 | MP0000343_altered_response_to | 0.98473381 |
| 68 | MP0002254_reproductive_system_inflammat | 0.96669513 |
| 69 | MP0004883_abnormal_blood_vessel | 0.91656399 |
| 70 | MP0005390_skeleton_phenotype | 0.90324897 |
| 71 | MP0008004_abnormal_stomach_pH | 0.90073501 |
| 72 | MP0003448_altered_tumor_morphology | 0.89208678 |
| 73 | MP0005166_decreased_susceptibility_to | 0.87224515 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.86883401 |
| 75 | MP0003828_pulmonary_edema | 0.86557342 |
| 76 | MP0000490_abnormal_crypts_of | 0.79251787 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.78404562 |
| 78 | MP0000249_abnormal_blood_vessel | 0.78122585 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.77502583 |
| 80 | MP0005164_abnormal_response_to | 0.76463353 |
| 81 | MP0001663_abnormal_digestive_system | 0.75637848 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.67622420 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 0.64207562 |
| 84 | MP0003045_fibrosis | 0.60225071 |
| 85 | MP0008874_decreased_physiological_sensi | 0.60106257 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.59195662 |
| 87 | MP0003795_abnormal_bone_structure | 0.58963395 |
| 88 | MP0000609_abnormal_liver_physiology | 0.57255807 |
| 89 | MP0004381_abnormal_hair_follicle | 0.54539423 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.51356010 |
| 91 | MP0003329_amyloid_beta_deposits | 0.50653102 |
| 92 | MP0005535_abnormal_body_temperature | 0.50457661 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.49763614 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.49688552 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.47333542 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.47263470 |
| 97 | MP0002139_abnormal_hepatobiliary_system | 0.46851580 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.46635788 |
| 99 | MP0005165_increased_susceptibility_to | 0.46239520 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.44574849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.48376721 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.89710635 |
| 3 | Myositis (HP:0100614) | 4.59158971 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.55804103 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.52792486 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.43373191 |
| 7 | Agammaglobulinemia (HP:0004432) | 4.42638240 |
| 8 | Meningitis (HP:0001287) | 4.41893778 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.40925834 |
| 10 | Orchitis (HP:0100796) | 4.25866308 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.15860408 |
| 12 | Optic neuritis (HP:0100653) | 4.15860408 |
| 13 | Vasculitis (HP:0002633) | 3.97348573 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 3.91385618 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.90427675 |
| 16 | Cellulitis (HP:0100658) | 3.75119396 |
| 17 | Stomatitis (HP:0010280) | 3.74923437 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.74275864 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.73432204 |
| 20 | Obstructive lung disease (HP:0006536) | 3.73432204 |
| 21 | Increased IgE level (HP:0003212) | 3.64689395 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61888103 |
| 23 | Recurrent viral infections (HP:0004429) | 3.61823642 |
| 24 | Urticaria (HP:0001025) | 3.57579274 |
| 25 | Petechiae (HP:0000967) | 3.42405623 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.39792989 |
| 27 | Recurrent skin infections (HP:0001581) | 3.37547670 |
| 28 | Recurrent bronchitis (HP:0002837) | 3.35452304 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.33116213 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.33116213 |
| 31 | IgM deficiency (HP:0002850) | 3.30501253 |
| 32 | Encephalitis (HP:0002383) | 3.30074542 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.28732259 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.26622547 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 3.24075932 |
| 36 | Recurrent sinusitis (HP:0011108) | 3.22793691 |
| 37 | Increased IgM level (HP:0003496) | 3.11923817 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.11393425 |
| 39 | Colitis (HP:0002583) | 3.11246283 |
| 40 | Prolonged bleeding time (HP:0003010) | 3.01722917 |
| 41 | Lymphopenia (HP:0001888) | 3.00661581 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 2.95324355 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.95222049 |
| 44 | Purpura (HP:0000979) | 2.84772944 |
| 45 | Hypertensive crisis (HP:0100735) | 2.81203205 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.78254895 |
| 47 | Abnormality of T cells (HP:0002843) | 2.77906415 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.77301175 |
| 49 | IgG deficiency (HP:0004315) | 2.76886546 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.72776832 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.72445222 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.67212666 |
| 53 | Epistaxis (HP:0000421) | 2.67184841 |
| 54 | Skin rash (HP:0000988) | 2.67119248 |
| 55 | Hemoptysis (HP:0002105) | 2.66217872 |
| 56 | Chest pain (HP:0100749) | 2.64438018 |
| 57 | Granulocytopenia (HP:0001913) | 2.62467726 |
| 58 | Emphysema (HP:0002097) | 2.61911344 |
| 59 | Recurrent pneumonia (HP:0006532) | 2.59495199 |
| 60 | Osteomyelitis (HP:0002754) | 2.59306001 |
| 61 | IgA deficiency (HP:0002720) | 2.55654024 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.54070249 |
| 63 | Pustule (HP:0200039) | 2.53928690 |
| 64 | Papilloma (HP:0012740) | 2.53664662 |
| 65 | Verrucae (HP:0200043) | 2.53664662 |
| 66 | Sepsis (HP:0100806) | 2.53654259 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.53128392 |
| 68 | Leukocytosis (HP:0001974) | 2.53098561 |
| 69 | Recurrent lower respiratory tract infections (HP:0002783) | 2.49308241 |
| 70 | T lymphocytopenia (HP:0005403) | 2.48391174 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.46984429 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.46984429 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 2.46984429 |
| 74 | B lymphocytopenia (HP:0010976) | 2.46111555 |
| 75 | Chronic diarrhea (HP:0002028) | 2.45732751 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.45699843 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.42277404 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.40819140 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.40167393 |
| 80 | Chronic otitis media (HP:0000389) | 2.38511276 |
| 81 | Gingivitis (HP:0000230) | 2.37571379 |
| 82 | Gangrene (HP:0100758) | 2.37348386 |
| 83 | Arterial thrombosis (HP:0004420) | 2.35185593 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.31359702 |
| 85 | Restrictive lung disease (HP:0002091) | 2.31225326 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.28993920 |
| 87 | Arthralgia (HP:0002829) | 2.27423312 |
| 88 | Gingival bleeding (HP:0000225) | 2.26448886 |
| 89 | Pulmonary embolism (HP:0002204) | 2.26113405 |
| 90 | Anorexia (HP:0002039) | 2.20862241 |
| 91 | Skin ulcer (HP:0200042) | 2.19503595 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.19001452 |
| 93 | Joint swelling (HP:0001386) | 2.18431122 |
| 94 | Eosinophilia (HP:0001880) | 2.17181282 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 2.14859962 |
| 96 | Prostate neoplasm (HP:0100787) | 2.11673938 |
| 97 | Increased serum ferritin (HP:0003281) | 2.06239873 |
| 98 | Acute hepatic failure (HP:0006554) | 2.03954360 |
| 99 | Loss of speech (HP:0002371) | 2.00644053 |
| 100 | Episodic fever (HP:0001954) | 1.95346038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.22905141 |
| 2 | ERN1 | 3.20360961 |
| 3 | RIPK4 | 3.16015101 |
| 4 | IRAK4 | 2.85183173 |
| 5 | TBK1 | 2.66625609 |
| 6 | PRPF4B | 2.61534992 |
| 7 | MAP3K14 | 2.41557756 |
| 8 | IKBKE | 2.37474039 |
| 9 | TYK2 | 2.37242943 |
| 10 | BLK | 2.26862599 |
| 11 | TESK2 | 2.11253138 |
| 12 | MAP2K3 | 2.08140086 |
| 13 | MAP3K11 | 2.06838148 |
| 14 | TAOK3 | 2.01270964 |
| 15 | JAK3 | 1.89373631 |
| 16 | IKBKB | 1.84764300 |
| 17 | BCKDK | 1.84644296 |
| 18 | SYK | 1.84170136 |
| 19 | GRK6 | 1.79226522 |
| 20 | TNK2 | 1.79073640 |
| 21 | BTK | 1.75464387 |
| 22 | FES | 1.73724035 |
| 23 | TLK1 | 1.71618691 |
| 24 | TXK | 1.66620356 |
| 25 | KIT | 1.66285072 |
| 26 | SMG1 | 1.62591529 |
| 27 | CSK | 1.61198130 |
| 28 | VRK1 | 1.57507835 |
| 29 | MAP3K3 | 1.56772111 |
| 30 | TAOK2 | 1.43343976 |
| 31 | ZAP70 | 1.40669072 |
| 32 | PIM2 | 1.39688452 |
| 33 | CSF1R | 1.36256142 |
| 34 | LYN | 1.34070115 |
| 35 | JAK1 | 1.34064378 |
| 36 | KDR | 1.30252441 |
| 37 | MAP3K13 | 1.27531719 |
| 38 | FGFR4 | 1.25856480 |
| 39 | HCK | 1.24478598 |
| 40 | NME2 | 1.23772543 |
| 41 | DAPK3 | 1.19744441 |
| 42 | LCK | 1.19015067 |
| 43 | MAP3K1 | 1.14848475 |
| 44 | ARAF | 1.11724655 |
| 45 | IRAK3 | 1.11570557 |
| 46 | ITK | 1.11181548 |
| 47 | TAOK1 | 1.10433082 |
| 48 | EPHB1 | 1.06604868 |
| 49 | FGR | 1.05654394 |
| 50 | RPS6KA5 | 1.03978325 |
| 51 | PIM1 | 0.97335946 |
| 52 | JAK2 | 0.95304544 |
| 53 | MARK3 | 0.93372122 |
| 54 | MATK | 0.92633996 |
| 55 | SIK3 | 0.89599220 |
| 56 | BMPR2 | 0.87925098 |
| 57 | ZAK | 0.85711264 |
| 58 | SIK2 | 0.84095118 |
| 59 | TEC | 0.82863244 |
| 60 | SIK1 | 0.82141137 |
| 61 | HIPK2 | 0.81419022 |
| 62 | PRKCQ | 0.80643691 |
| 63 | VRK2 | 0.78254171 |
| 64 | STK10 | 0.74224267 |
| 65 | EPHA3 | 0.71058276 |
| 66 | MAPK12 | 0.67267208 |
| 67 | IRAK1 | 0.63794799 |
| 68 | CHUK | 0.62960710 |
| 69 | MAPK11 | 0.62189400 |
| 70 | MAPK7 | 0.60093088 |
| 71 | MAPKAPK3 | 0.57936008 |
| 72 | PDK1 | 0.56169237 |
| 73 | FGFR3 | 0.55281359 |
| 74 | CDC42BPA | 0.55181721 |
| 75 | LRRK2 | 0.53234462 |
| 76 | STK4 | 0.51848398 |
| 77 | MAP2K2 | 0.50310244 |
| 78 | TRIB3 | 0.49764726 |
| 79 | GRK7 | 0.49645071 |
| 80 | PRKD2 | 0.46817990 |
| 81 | CDK12 | 0.45501986 |
| 82 | PIK3CG | 0.42559228 |
| 83 | CDK9 | 0.42527469 |
| 84 | AURKA | 0.42025887 |
| 85 | TESK1 | 0.41894758 |
| 86 | MAPKAPK2 | 0.41804469 |
| 87 | CDK4 | 0.41585025 |
| 88 | NEK9 | 0.40620440 |
| 89 | MOS | 0.40444282 |
| 90 | TGFBR2 | 0.38919510 |
| 91 | PRKCD | 0.38673293 |
| 92 | PTK2B | 0.37085503 |
| 93 | FYN | 0.35321472 |
| 94 | MARK2 | 0.34312792 |
| 95 | DYRK1B | 0.34306856 |
| 96 | RPS6KC1 | 0.33762558 |
| 97 | RPS6KL1 | 0.33762558 |
| 98 | PDPK1 | 0.33109183 |
| 99 | IRAK2 | 0.32213564 |
| 100 | PKN1 | 0.31770404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.01705804 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.77574321 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.61544805 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.57107520 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.48869766 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.39857962 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.17188709 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.92325187 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88328533 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60488889 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.60150745 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31586718 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.16114609 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07507629 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06380073 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00661581 |
| 17 | Alcoholism_Homo sapiens_hsa05034 | 1.82624611 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81679881 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79041271 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78776160 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75946335 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.69200652 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66494857 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.63770225 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62804898 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.57151181 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54597325 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50169773 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49383674 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.40936597 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34575630 |
| 32 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.32400262 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21589166 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19122449 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18784187 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17625801 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14409812 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.11613680 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11540627 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11196467 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03406683 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03107844 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99432275 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 0.95085587 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.93036958 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91841164 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 0.91802384 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.91041279 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90997100 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.86360118 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83527248 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.76362447 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.74643796 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74300440 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73733675 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.67734970 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64872076 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63018314 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.62199570 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54039014 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45811005 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43748737 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42391041 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39970433 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39582850 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39309133 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37861528 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35203309 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33269254 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31151979 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30630962 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.30058511 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29172091 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27718394 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26743343 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25306301 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25218017 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21490848 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21138408 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20329241 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18525273 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.18486174 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.16929166 |
| 84 | Ribosome_Homo sapiens_hsa03010 | 0.15393058 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14537011 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.13334184 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12782727 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.12480544 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11383986 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.11194262 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07833867 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06278698 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.05176536 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.04884294 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04281586 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.03148295 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.03004918 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.02512782 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.02392918 |
| 100 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.01405248 |

